Scoop: Activists' attempt to take over infamous Martin Shkreli company fails, as ‘Pharma Bro’ votes from prison
An activist group’s efforts to gain control of Phoenixus — the parent company to Martin Shkreli’s infamous Turing Pharmaceuticals, now rennamed as Vyera — failed on Monday, as shareholders voted to keep four of the five current directors. The vote was influenced by the “Pharma Bro” himself, who voted on his shares from prison.
The directors — Miguel Barron, William Rueckert, Jordan Walker and William Hess — were re-elected in a landslide vote, with many of them getting more than 70% of the votes in favor. However, shareholders voted overwhelmingly against re-electing Averill Powers, CEO and chairman.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 117,600+ biopharma pros reading Endpoints daily — and it's free.